New Study Suggests Additional Upside for Harvard Apparatus (HART), Maxim Says
Tweet Send to a Friend
Maxim Group analyst Pamela Bassett reiterated a Buy rating and $19 price target on Harvard Apparatus Regenerative Technology (NASDAQ: HART) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


